» Articles » PMID: 29239571

Spatial-temporal Analysis of Prostate Cancer Incidence from the Pennsylvania Cancer Registry, 2000-2011

Overview
Journal Geospat Health
Date 2017 Dec 15
PMID 29239571
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Prostate cancer is the most common cancer diagnosed among males, and the incidence in Pennsylvania, USA is considerably higher than nationally. Knowledge of regional differences and time trends in prostate cancer incidence may contribute to a better understanding of aetiologic factors and racial disparities in outcomes, and to improvements in preventive intervention and screening efforts. We used Pennsylvania Cancer Registry data on reported prostate cancer diagnoses between 2000 and 2011 to study the regional distribution and temporal trends of prostate cancer incidence in both Pennsylvania White males and Philadelphia metropolitan area Black males. For White males, we generated and mapped county-specific age-adjusted incidence and standardised incidence ratios by period cohort, and identified spatial autocorrelation and local clusters. In addition, we fitted Bayesian hierarchical generalised linear Poisson models to describe the temporal and aging effects separately in Whites state-wide and metropolitan Philadelphia blacks. Incidences of prostate cancer among white males declined from 2000-2002 to 2009-2011 with an increasing trend to some extent in the period 2006-2008 and significant variation across geographic regions, but less variation exists for metropolitan Philadelphia including majority of Black patients. No significant aging effect was detected for White and Black men, and the peak age group for prostate cancer risk varied by race. Future research should seek to identify potential social and environmental risk factors associated with geographical/racial disparities in prostate cancer. As such, there is a need for more effective surveillance so as to detect, reduce and control the cancer burden associated with prostate cancer.

Citing Articles

Application of Geographic Information Systems (GIS) in the Study of Prostate Cancer Disparities: A Systematic Review.

El Khoury C Cancers (Basel). 2024; 16(15).

PMID: 39123443 PMC: 11312136. DOI: 10.3390/cancers16152715.


Navigation-Based Telehealth Informed Decision-Making for Prostate Cancer Screening in Black Men.

Ba D, Kayembe C, Littlejohn J, Van Scoy L, VanDyke E, Williams J Curr Oncol. 2024; 31(7):3698-3712.

PMID: 39057145 PMC: 11275421. DOI: 10.3390/curroncol31070273.


Spatial-temporal Bayesian accelerated failure time models for survival endpoints with applications to prostate cancer registry data.

Wang M, Li Z, Lu J, Zhang L, Li Y, Zhang L BMC Med Res Methodol. 2024; 24(1):86.

PMID: 38589783 PMC: 11003030. DOI: 10.1186/s12874-024-02201-w.


Spatio-temporal mapping of breast and prostate cancers in South Iran from 2014 to 2017.

Montazeri M, Hoseini B, Firouraghi N, Kiani F, Raouf-Mobini H, Biabangard A BMC Cancer. 2020; 20(1):1170.

PMID: 33256668 PMC: 7708260. DOI: 10.1186/s12885-020-07674-8.


Spatial Autocorrelation of Breast and Prostate Cancer in Slovakia.

Vilinova K Int J Environ Res Public Health. 2020; 17(12).

PMID: 32575748 PMC: 7344400. DOI: 10.3390/ijerph17124440.


References
1.
DeSantis C, Naishadham D, Jemal A . Cancer statistics for African Americans, 2013. CA Cancer J Clin. 2013; 63(3):151-66. DOI: 10.3322/caac.21173. View

2.
Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J . Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control. 2007; 19(2):175-81. PMC: 3064270. DOI: 10.1007/s10552-007-9083-8. View

3.
Schroder F, Hugosson J, Roobol M, Tammela T, Ciatto S, Nelen V . Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009; 360(13):1320-8. DOI: 10.1056/NEJMoa0810084. View

4.
Giovannucci E, Liu Y, Platz E, Stampfer M, Willett W . Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007; 121(7):1571-8. PMC: 2430098. DOI: 10.1002/ijc.22788. View

5.
Patel A, Klein E . Risk factors for prostate cancer. Nat Clin Pract Urol. 2009; 6(2):87-95. DOI: 10.1038/ncpuro1290. View